meprobamate has been researched along with Intracranial Arteriosclerosis in 2 studies
Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KOZLOWSKI, VL | 1 |
| STERN, FH | 1 |
2 other studies available for meprobamate and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
Meprobamate-promazine therapy for aged psychiatric patients with chronic brain syndrome associated with arteriosclerosis. A preliminary report.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Brain; Brain Damage, Chronic; Intracranial Arterioscleros | 1961 |
A NEW DRUG (TYBAMATE) EFFECTIVE IN THE MANAGEMENT OF CHRONIC BRAIN SYNDROME.
Topics: Biomedical Research; Brain; Brain Damage, Chronic; Brain Diseases; Carbamates; Drug Therapy; Geriatr | 1964 |